Ronald W. Barrett - Sep 7, 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Sep 7, 2021
Transactions value $
$0
Form type
3
Date filed
9/9/2021, 05:26 PM
Previous filing
Jun 11, 2021
Next filing
Jun 16, 2022

No securities are beneficially owned.